000538 云南白药
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)10.4467.8227.35414.51810.783
总资产报酬率 ROA (%)7.6445.6815.21610.5198.076
投入资产回报率 ROIC (%)8.8746.5436.14112.6809.594

边际利润分析
销售毛利率 (%)26.50626.32327.15027.75228.564
营业利润率 (%)12.3519.2399.58220.80515.989
息税前利润/营业总收入 (%)11.6568.3158.86220.06315.720
净利润/营业总收入 (%)10.5417.7847.69116.83114.067

收益指标分析
经营活动净收益/利润总额(%)83.614130.329133.10163.48465.694
价值变动净收益/利润总额(%)18.7337.353-25.41438.70735.913
营业外收支净额/利润总额(%)-0.2590.169-0.101-0.160-0.355

偿债能力分析
流动比率 (X)2.8512.6313.5783.1504.649
速动比率 (X)2.3452.0422.9192.4483.428
资产负债率 (%)25.80527.74526.5600.30623.275
带息债务/全部投入资本 (%)11.20513.75713.88514.0945.676
股东权益/带息债务 (%)770.454607.468602.950590.8581,617.904
股东权益/负债合计 (%)287.336260.266275.012225.491328.237
利息保障倍数 (X)-17.585-8.849-12.480-28.322-74.253

营运能力分析
应收账款周转天数 (天)87.70080.28253.14130.74223.615
存货周转天数 (天)90.395109.623131.575173.010193.474